Results 251 to 260 of about 75,327 (314)

Plasminogen activator inhibitor 2 and urokinase‐type plasminogen activator in plasma and leucocytes in patients with severe sepsis [PDF]

, 2000
L. A. Robbie, Stephen Dummer, N. A. Booth, Gillian Adey, Bruce Bennett   +4 more
openalex   +1 more source

Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis

, 1996
Fabio Farinati, László Herszényi, M. PIebani, Paolo Carraro, Massimo De Paoli, Romilda Cardin, Giovanni Roveroni, Massimo Rugge, Donato Nitti, Francesco Grigioni, Antonietta D’Errico, R. Naccarato   +11 more
openalex   +1 more source

Effect of Individual Caseins on Plasminogen Activation by Bovine Urokinase-Type and Tissue-Type Plasminogen Activators

, 1995
I. Politis, Jeffrey H. White, Boris Zavizion, John J. Goldberg, Mingruo Guo, Paul S. Kindstedt   +5 more
openalex   +1 more source

Urokinase-type plasminogen activator-mediated crosstalk between N-cadherin and β-catenin promotes wound healing.

J Cell Sci, 2021
Diaz A, Martin-Jimenez C, Xu Y, Merino P, Woo Y, Torre E, Yepes M.   +6 more
europepmc   +1 more source

Effect of cyclic AMP on urokinase-type plasminogen activator receptor and fibrinolytic factors in a human osteoblast-like cell line

, 1995
Tohgo Nonaka, Hiroshi Matsumoto, Wataru Shimada, Ichiro Miyagi, K Okada, Hideharu Fukao, Shigeru Ueshima, Hiraku Kikuchi, Seisuke Tanaka, Osamu Matsuo   +9 more
openalex   +1 more source

92 Single chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1

, 1996

openalex   +1 more source

A comparative analysis of serial measurements of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and C-reactive protein in patients with moderate COVID-19: a single center study from India

, 2022
Kakar A, Rani P, Batra T, Hasan R, Choudhury S.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Urokinase‐type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)‐mediated sodium retention in experimental nephrotic syndrome

Acta Physiologica, 2019
In nephrotic syndrome, aberrantly filtered plasminogen (plg) is converted to active plasmin by tubular urokinase‐type plasminogen activator (uPA) and thought to lead to sodium retention by proteolytic activation of the epithelial sodium channel (ENaC ...
Bernhard N. Bohnert, Sophie Daiminger, Matthias Wörn, Florian Sure, Tobias Staudner, Alexandr V. Ilyaskin, Firas Batbouta, A. Janessa, Jonas C Schneider, Daniel Essigke, S. Kanse, S. Haerteis, C. Korbmacher, F. Artunc   +13 more
semanticscholar   +1 more source

Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer

Translational medicine @ UniSa, 2016
The urokinase (uPA)-type plasminogen activator receptor (uPAR) is a GPI-anchored receptor that focuses urokinase (uPA) proteolytic activity on the cell surface.
N. Montuori, A. Pesapane, F. Rossi, V. Giudice, A. de Paulis, C. Selleri, P. Ragno   +6 more
semanticscholar   +1 more source

The murine urokinase-type plasminogen activator gene

Biochemistry, 1987
The murine urokinase-type plasminogen activator (uPA) gene has been isolated from a BALB/c liver DNA cosmid library and its nucleotide sequence established. The gene is organized into 11 exons comprising 34.7% of the 6710 base pair (bp) region spanning the interval between the presumed transcription initiation and polyadenylation sites.
Jay L. Degen, Janice L. Heckel, E. Reich, Sandra J. Friezner Degen   +3 more
openaire   +3 more sources